Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predictors of Post-alteplase Different Subtypes of Hemorrhagic Transformation of Brain Infarction in the Middle East

NCT06337175 is registered in ClinicalTrials.gov with Kafrelsheikh University as lead sponsor.

NCT NCT06337175
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06337175 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predictors of Post-alteplase Different Subtypes of Hemorrhagic Transformation of Brain Infarction in the Middle East
Lead sponsor
Kafrelsheikh University
Phase
Phase 4
Overall status
Completed
Start date
June 1, 2021
Completion date
April 30, 2024
Enrollment
600 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alteplase adverse reaction, ischemic stroke